HYPR CIK: 1833769

Hyperfine, Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−1.17
FY22:
0.91
FY23:
4.76
FY24:
5.89
FY25:
6.75
(positive)
Change from FY21 to FY25
millions USD
FY21:
−64.9
FY22:
−73.9
FY23:
−48.1
FY24:
−43.2
FY25:
−37.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−64.1
FY22:
−72.9
FY23:
−47.1
FY24:
−42.2
FY25:
−36.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−64.9
FY22:
−73.2
FY23:
−44.2
FY24:
−40.7
FY25:
−35.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−64.9
FY22:
−73.2
FY23:
−44.2
FY24:
−40.7
FY25:
−35.6

All amounts in millions USD Data sources:SEC EDGARTwelve Data